Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection.
about
Review of the bioanalytical methods for the determination of methotrexate and its metabolites in in vitro, preclinical and clinical studies: Case studies and perspectives.Primary central nervous system lymphoma: essential points in diagnosis and management.Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma.Evaluation, Identification, and Management of Acute Methotrexate Toxicity in High-dose Methotrexate Administration in Hematologic Malignancies.Intraocular lymphoma.
P2860
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinical outcomes of primary i ...... itreal methotrexate injection.
@en
Clinical outcomes of primary i ...... itreal methotrexate injection.
@nl
type
label
Clinical outcomes of primary i ...... itreal methotrexate injection.
@en
Clinical outcomes of primary i ...... itreal methotrexate injection.
@nl
prefLabel
Clinical outcomes of primary i ...... itreal methotrexate injection.
@en
Clinical outcomes of primary i ...... itreal methotrexate injection.
@nl
P2093
P2860
P50
P1433
P1476
Clinical outcomes of primary i ...... itreal methotrexate injection.
@en
P2093
Ya-Jui Hsu
Yin-Kai Chen
P2860
P304
P356
10.1007/S00277-015-2582-X
P577
2016-01-06T00:00:00Z